OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Treatment of persistent COVID-19 in two B-cell-depleted patients with the monoclonal antibody Sotrovimab
David Totschnig, Daniel Doberer, Renate Haberl, et al.
IDCases (2022) Vol. 29, pp. e01528-e01528
Open Access | Times Cited: 10
David Totschnig, Daniel Doberer, Renate Haberl, et al.
IDCases (2022) Vol. 29, pp. e01528-e01528
Open Access | Times Cited: 10
Showing 10 citing articles:
Persistent COVID-19 in immunocompromised patients—Israeli society of infectious diseases consensus statement on diagnosis and management
Suzy Meijer, Yael Paran, Ana Belkin, et al.
Clinical Microbiology and Infection (2024) Vol. 30, Iss. 8, pp. 1012-1017
Closed Access | Times Cited: 11
Suzy Meijer, Yael Paran, Ana Belkin, et al.
Clinical Microbiology and Infection (2024) Vol. 30, Iss. 8, pp. 1012-1017
Closed Access | Times Cited: 11
SARS-CoV-2 Pre-Exposure Prophylaxis with Sotrovimab and Tixagevimab/Cilgavimab in Immunocompromised Patients—A Single-Center Experience
David Totschnig, Max Augustin, I Niculescu, et al.
Viruses (2022) Vol. 14, Iss. 10, pp. 2278-2278
Open Access | Times Cited: 12
David Totschnig, Max Augustin, I Niculescu, et al.
Viruses (2022) Vol. 14, Iss. 10, pp. 2278-2278
Open Access | Times Cited: 12
Resilience and Beyond the Acute Phase Challenges: Case Series on Prolonged COVID-19 Infection in Immunocompromised Individuals
Kridsanai Gulapa, Dararat Eksombatchai, Tananchai Petnak, et al.
Infection and Drug Resistance (2024) Vol. Volume 17, pp. 4727-4732
Open Access | Times Cited: 1
Kridsanai Gulapa, Dararat Eksombatchai, Tananchai Petnak, et al.
Infection and Drug Resistance (2024) Vol. Volume 17, pp. 4727-4732
Open Access | Times Cited: 1
The consequences of SARS-CoV-2 within-host persistence
Alex Sigal, Richard A. Neher, Richard Lessells
Nature Reviews Microbiology (2024)
Closed Access | Times Cited: 1
Alex Sigal, Richard A. Neher, Richard Lessells
Nature Reviews Microbiology (2024)
Closed Access | Times Cited: 1
Neutralizing anti-spike monoclonal antibodies for COVID-19 in vulnerable populations: lessons learned and future directions
Raymund R. Razonable
Expert Opinion on Biological Therapy (2023) Vol. 23, Iss. 7, pp. 619-631
Closed Access | Times Cited: 2
Raymund R. Razonable
Expert Opinion on Biological Therapy (2023) Vol. 23, Iss. 7, pp. 619-631
Closed Access | Times Cited: 2
Combination treatment of persistent COVID-19 in immunocompromised patients with remdesivir, nirmaltrevir/ritonavir and tixegavimab/cilgavimab
Tal Brosh‐Nissimov, Nir Maaravi, Daniel Leshin-Carmel, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 2
Tal Brosh‐Nissimov, Nir Maaravi, Daniel Leshin-Carmel, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 2
Sotrovimab in the treatment of coronavirus disease-2019 (COVID-19): a systematic review and meta-analysis of randomized clinical trials
Ana Flávia Amorim, Joselin Valeska Martinez-Sobalvarro, Larissa Helena Torres, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2024) Vol. 397, Iss. 12, pp. 9573-9589
Closed Access
Ana Flávia Amorim, Joselin Valeska Martinez-Sobalvarro, Larissa Helena Torres, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2024) Vol. 397, Iss. 12, pp. 9573-9589
Closed Access
Sotrovimab Treatment for COVID-19 Effective in a B-Cell-Depleted Patient After Anti-CD20 Treatment
Kazuyuki Murase, Kohichi Takada, Yohei Arihara, et al.
Cureus (2023)
Open Access
Kazuyuki Murase, Kohichi Takada, Yohei Arihara, et al.
Cureus (2023)
Open Access
Treatment Modalities for immunocompromised patients with Persistent, symptomatic COVID-19 Infection, literature review, and Recommendations
Sopiko Gogia, Valiko Begiashvili, Ola A Al-Ewaidat, et al.
Authorea (Authorea) (2023)
Open Access
Sopiko Gogia, Valiko Begiashvili, Ola A Al-Ewaidat, et al.
Authorea (Authorea) (2023)
Open Access
